The Ninth Circuit Court of Appeals has vacated the registrations of three dicamba herbicides — Bayer's Xtendimax, BASF's Engenia and Corteva's FeXapan — after finding that EPA substantially understated or failed to consider the social and economic costs.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.